Association of TRPV6, CLDN16, and SLC26A6 gene polymorphisms with the risk of nephrolithiasis and nephrocalcinosis in children with hypercalciuria
Abstract
Clinical and laboratory examinations were made in 56 children aged 1 to 16 years; out of them, 22 children were diagnosed as having nephrocalcinosis, 11 had nephrolithiasis in the presence of hypercalciuria, and 23 were found to have hypercalciuria without concrements and calcifications being formed in the urinary organs. The associations of single-nucleotide polymorphisms rs4987682 Thr681Met, rs4987667 Val378Met, rs4987657 Cysl57Arg of a gene calcium vanilloideae membrane channel TRPV6, rsl04893723 Glyl98Asp of a gene protein of dense intercellular contacts CLDN16, rsl3324142 Vall85Met of a gene union transporter SLC26A6 with the development of hypercalciuria, nephrolithiasis, and nephrocalcinosis were studied in children. TRPV6 gene polymorphism was is associated with the risk of nephrolithiasis and nephrocalcinosis in children with hypercalciuria. The predisposing factors were a homozygous genotype for the T-allele (TT) polymorphism rs4987682 C2042TThr681Met TRPV6 gene and genotype AA polymorphism rs4987667 G1132A Val378Met TRPV6 gene. Examination of bone mineral density in children with hypercalciuria revealed osteopenia in 45% of the cases, which increased the risk of fractures.
About the Authors
S. V. MaltsevRussian Federation
T. V. Mikhailova
Russian Federation
O. A. Kravtsova
Russian Federation
Z. R. Nurieva
Russian Federation
References
1. Bid H.K., Kumar A., Kapoor R., Mittal R.D. Association of Vitamin D Receptor (VDR) Gene Polymorphism (Fok-I) with Calcium oxalate Nephrolithiasis. J Endourol 2005; 19: 111-115.
2. Monico C.G., Milliner D.S. Genetic determinants of urolithia-sis. Nature Reviews Nephrol 2011; 8: 3: 151-162.
3. Park S. Y., Mun H.C., Eom Y.S. et al. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914. Gin Endo-crinol (Oxf) 2013; 78: 5: 687-693.
4. Chernova M.N., Jiang L., Friedman D.J. et al. Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity. J Biol Chem 2005; 280: 8564-8580.
5. Giuffre M., La Placa S., Carta M. et al. Hypercalciuria and kidney calcifications in terminal 4q deletion syndrome: further evidence for a putative gene on 4q. Am J Med Genet 2004; 126A: 186-190.
6. Goodman И.О., Brommage R., Assimos D.G. et al. Genes in id-iopathic calcium oxalate stone disease. World J Urol 1997; 15: 186-194.
7. Gunes S., Bilen C.Y., Kara N. et al. Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res 2006; 34: 47-52.
8. Rendina D. MossettiG., Viceconti R. et al. Association between vitamin D receptor gene polymorphisms and fasting idiopath-ic hypercalciuria in recurrent stone-forming patients. Urology 2004; 4: 833-838.
9. Dimke H, Desai P., Borovac J. et al. Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion. Am J Physiol Renal Physiol 2013; 304: 6: F761-769.
10. VezzoliG., Terranegra A., Soldati L. Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis. Curr OpinNephrol Hypertens 2012; 21: 4: 355-61.
11. Kausalya P.J., Amasheh S., Gunzel D. etal. Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of claudin-16. J Clin Invest 2006; 116: 878-891.
12. Mutter D., Kausalya P.J., Bockenhauer D. et al. Unusual clinical presentation and possible rescue of a novel claudin-16 mutation. J Clin Endocr Metab 2006; 91: 3076-3079.
13. Thorleifsson G., Holm H, Edvardsson V. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nature Genet 2009; 41: 926-930.
14. Weber S., Schneider L., Peters M. et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with
15. hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001; 12: 1872-1881.
16. Morin P.J. Protein family review the claudins. Genome Biology 2009; 10:235.
17. Reed B.Y., Gitomer W.L., Heller HJ. et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocr Metab 2002; 87: 1476-1485.
18. Reed B. Y, Heller H.J., Gitomer W.L. et al. Mapping a gene defect in absorptive hypercalciuria to chromosome Iq23.3-q24. J Clin Endocr Metab 1999; 84: 3907-3913.
19. Moreira Guimaraes Penido M.G., deSousa TavaresM., Campos Linhares M. et al. Longitudinal study of bone mineral density in children with idiopathic hypercalciuria. Pediat Nephrol 2012; 27: 1:123-130.
20. Zerwekh J.E. Bone disease and hypercalciuria in children. Pediat Nephrol 2010; 25: 3: 395-401.
21. Suzuki M., Ohki G., Ishibashi K, Imai M. A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. Biochem Biophys Res Commun 2002; 291: 278— 285.
22. HoenderopJ.G., Voets Т., HoefsS. etal. Homo-andheterotet-rameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6. EMBO J 2003; 22: 776-785.
23. Nijenhuis Т., Hoenderop J.G., Bindels R. TRPV5 and TRPV6 in Ca2+ (re)absorption: regulating Ca2+ entry at the gate. Pflugers Arch 2005; 451: 181-192.
24. Jiang Z., Asplin J.R., Evan A.P. et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nature Genet 2006; 38: 474-478.
25. Yoo J., Seo В., Kim Y. SNPAnalyzer: a web-based integrated workbench for single-nucleotide polymorphism analysis. Nucleic Acids Research 2005; 33: 483-488.
Review
For citations:
Maltsev S.V., Mikhailova T.V., Kravtsova O.A., Nurieva Z.R. Association of TRPV6, CLDN16, and SLC26A6 gene polymorphisms with the risk of nephrolithiasis and nephrocalcinosis in children with hypercalciuria. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2015;60(5):210-215. (In Russ.)